Cabaletta Bio, Inc. (CABA)
NASDAQ: CABA · Real-Time Price · USD
2.400
+0.070 (3.00%)
At close: Jan 3, 2025, 4:00 PM
2.420
+0.020 (0.83%)
After-hours: Jan 3, 2025, 7:54 PM EST
Cabaletta Bio Stock Forecast
CABA's stock price has decreased by -89.17% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 9 analysts with 12-month price forecasts for Cabaletta Bio stock have an average target of 27.22, with a low estimate of 6.00 and a high estimate of 50. The average target predicts an increase of 1,034.17% from the current stock price of 2.40.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Cabaletta Bio stock from 9 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 | Jan '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 4 | 5 | 5 | 5 | 5 |
| Buy | 5 | 5 | 5 | 5 | 2 | 2 |
| Hold | 0 | 0 | 0 | 0 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 10 | 9 | 10 | 10 | 9 | 9 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Evercore ISI Group | Evercore ISI Group | Buy → Hold Downgrades $15 → $6 | Buy → Hold | Downgrades | $15 → $6 | +150.00% | Dec 20, 2024 |
| Wells Fargo | Wells Fargo | Buy → Hold Downgrades $12 → $6 | Buy → Hold | Downgrades | $12 → $6 | +150.00% | Dec 19, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $25 | Strong Buy | Reiterates | $25 | +941.67% | Nov 18, 2024 |
| Wells Fargo | Wells Fargo | Buy Maintains $20 → $12 | Buy | Maintains | $20 → $12 | +400.00% | Nov 15, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $25 | Strong Buy | Reiterates | $25 | +941.67% | Nov 15, 2024 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-2.36
from -1.65
EPS Next Year
-2.67
from -2.36
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | n/a | n/a | 15.8M | |||
| Avg | n/a | n/a | 1.9M | |||
| Low | n/a | n/a | n/a |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | - | - | - | |||
| Avg | - | - | - | |||
| Low | - | - | - |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | -2.21 | -1.93 | -1.66 | |||
| Avg | -2.36 | -2.67 | -2.70 | |||
| Low | -2.36 | -3.19 | -3.55 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | - | - | - | |||
| Avg | - | - | - | |||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.